Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Considerations for successful therapeutic immunization in HIV cure.
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Determinants of HIV-1 Late Presentation in Patients Followed in Europe.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Diversity and Evolution of HIV and HCV.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
Ultrasound-Based Assessment of Preperitoneal Fat as a Surrogate Marker of Cardiovascular Risk: Comparative Study Between People Living With HIV and Controls.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.